These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 79789)

  • 1. Impairment of renal function in patients on 1alpha-hydroxycholecalciferol.
    Lancet; 1978 Aug; 2(8086):427-8. PubMed ID: 79789
    [No Abstract]   [Full Text] [Related]  

  • 2. Impairment of renal function in patients on 1alpha-hydroxycholecalciferol.
    Winterborn MH; Mace PJ; Heath DA; White RH
    Lancet; 1978 Jul; 2(8081):150-1. PubMed ID: 78344
    [No Abstract]   [Full Text] [Related]  

  • 3. [1 alpha-hydroxycholecalciferol treatment of a 2-year-old child with severe renal osteodystrophy].
    Hansen HE; Christensen MS; Nielsen HE; Johannsen A
    Ugeskr Laeger; 1978 Apr; 140(16):919-21. PubMed ID: 653843
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy.
    Henderson RG; Kanis JA; Ledingham JG; Oliver DO; Russel RG; Smith R; Walton RJ
    Calcif Tissue Res; 1976 Aug; 21 Suppl():221-5. PubMed ID: 782661
    [No Abstract]   [Full Text] [Related]  

  • 5. 1alpha-Hydroxycholecalciferol in children with renal osteodystrophy.
    Postlethwaite RJ; Houston IB
    Calcif Tissue Res; 1977 May; 22 Suppl():371-5. PubMed ID: 912549
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; De Luca HF
    Calcif Tissue Res; 1976 Aug; 21 Suppl():226-35. PubMed ID: 782662
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 8. 1alpha-hydroxycholecalciferol and renal function.
    Lund B; Sørensen OH; Lund B
    Lancet; 1978 Sep; 2(8092 Pt 1):731. PubMed ID: 80649
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications].
    García de Vinuesa S; Barril G; Luño J; Alles A; Jofré R; Pérez García R; Olivas E; López Gómez JM; Valderrábano F
    Rev Clin Esp; 1980 Dec; 159(5):317-22. PubMed ID: 7221095
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of renal bone disease with 1-alpha hydroxycholecalciferol].
    Shasha SM; Vinaver J; Chaimovitz C; Mazor J; Better OS
    Harefuah; 1976 Jul; 91(1-2):16-7. PubMed ID: 964770
    [No Abstract]   [Full Text] [Related]  

  • 11. [1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy].
    Chalmers TM; Davie MW; Hunter JO; Szaz KF
    J Urol Nephrol (Paris); 1974 Dec; 80(12):981. PubMed ID: 4617778
    [No Abstract]   [Full Text] [Related]  

  • 12. 1alpha-hydroxycholecalciferol: a promising therapeutic approach for renal osteodystrophy.
    Gotloib L; Mines M; Mazur Y; Sklan D; Garmizo AL; Jancu J; Israeli M; Malul M
    Isr J Med Sci; 1978 Jul; 14(7):731-5. PubMed ID: 681163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of uraemic osteopathy. II. The effect of 5,6-trans-25-hydroxycholecalciferol in terminal renal failure.
    von Herrath D; Kraft D; Grigoleit H; Schaefer K
    Ger Med; 1973; 3(3-4):93-5. PubMed ID: 4803059
    [No Abstract]   [Full Text] [Related]  

  • 14. Symptomatic renal osteodystrophy after renal transplantation: treatment with 1-alpha-hydroxycholecalciferol.
    Williams PS; Hillis AN; Carty AJ; Sells RA; Bone JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2227-8. PubMed ID: 3274500
    [No Abstract]   [Full Text] [Related]  

  • 15. A model for clinical research studies of renal osteodystrophy in children.
    Norman ME; Mazur A; Gruskin AB
    Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
    [No Abstract]   [Full Text] [Related]  

  • 16. 1-alpha-hydroxycholecalciferol for renal osteodystrophy.
    Ahmad R; Large B
    Br Med J; 1977 Oct; 2(6093):1027. PubMed ID: 922379
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.
    Eke FU; Winterborn MH
    Arch Dis Child; 1983 Oct; 58(10):810-3. PubMed ID: 6357106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 1 alpha-hydroxycholecalciferol (1 alpha-OH-D3) and eel calcitonin derivative in experimental renal osteodystrophy].
    Minatoguchi T
    Nihon Jinzo Gakkai Shi; 1982 Oct; 24(10):1157-71. PubMed ID: 7161947
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
    von Herrath D; Kraft D; Grigoleit HG; Schaefer K
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
    [No Abstract]   [Full Text] [Related]  

  • 20. 1alpha-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy.
    Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
    Nephron; 1976; 16(5):359-70. PubMed ID: 1264309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.